首页|Andrographolide inhibits IL-1 beta release in bone marrow-derived macrophages and monocyte infiltration in mouse knee joints induced by monosodium urate
Andrographolide inhibits IL-1 beta release in bone marrow-derived macrophages and monocyte infiltration in mouse knee joints induced by monosodium urate
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NSTL
Elsevier
Andrographolide (AND) is the major diterpenoid in A. paniculata with wide clinical application and has been shown to be a potent anti-inflammatory agent. Gout is the leading inflammatory disease of the joints, and the deposition of urate in the articular cavity attracts immune cells that release inflammatory cytokines. Monosodium urate (MSU) is known to be one of the activators of the NLRP3 (NLR family pyrin domain containing 3) inflammasome. After activation, the NLRP3 inflammasome releases interleukin-1 (IL-1 beta), which causes the development of many inflammatory diseases. The aim of the present study was to investigate whether AND attenuates the release of IL-1 beta mediated by the NLRP3 inflammasome. The effects of AND were studied in bone marrow-derived macrophages (BMDMs) treated with lipopolysaccharide (LPS) and MSU and in mice with MSUinduced joint inflammation. AND suppressed MSU phagocytosis dose-dependently and markedly inhibited LPS-and MSU-induced IL-1 beta release in BMDMs. Moreover, AND pretreatment inhibited the LPS-induced NLRP3 inflammasome priming stage by inhibiting the IKK/NF kappa B signaling pathway, which resulted in decreased protein expression of NLRP3 and proIL-1 beta. AND induced HO-1 protein expression in a dose-dependent manner and attenuated MSU-induced ROS generation. Silencing HO-1 mitigated AND inhibition of LPS/MSU-induced IL-1 beta release in J774A.1 cells. In addition, AND decreased MSU-mediated ASC binding to NLRP3. Oral administration of AND attenuated MSU-induced monocyte infiltration in mouse knee joints. These results suggest that the working mechanisms by which AND down-regulates MSU-induced joint inflammation might be via HO-1 induction and attenuation of ROS-mediated NLRP3 inflammasome assembly and subsequent IL-1 beta release.
NSTL
Elsevier
